SCHEMBL18485941

SCHEMBL18485941

C[C@H](Oc1nccnc1-c1ccc(I)cc1)c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 6/20 0.38
▸ PLK3 Q9H4B4 6/20 0.38
▸ CYP2C9 P11712 1/20 0.36
▸ SCN1A P35498 2/20 0.33
▸ SCN5A Q14524 2/20 0.33
▸ SCN8A Q9UQD0 2/20 0.33
▸ MAPK3 P27361 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ FFAR2 O15552 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ IKBKE Q14164 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ LPAR1 Q92633 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18485943 0.88 L3MBTL1 (0.36) PLK1PLK3CYP2C9SCN1ASCN5A
SCHEMBL19205718 0.87 JAK2 (0.37) PLK1PLK3CYP2C9SCN1ASCN5A
SCHEMBL19205646 0.87 JAK2 (0.37) PLK1PLK3CYP2C9SCN1ASCN5A
SCHEMBL19205645 0.87 JAK2 (0.37) PLK1PLK3CYP2C9SCN1ASCN5A
SCHEMBL19205613 0.82 ADRA2A (0.41) PLK1PLK3CYP2C9ADRA2AADRA2B
SCHEMBL19205692 0.82 ADRA2A (0.41) PLK1PLK3CYP2C9ADRA2AADRA2B
SCHEMBL19205615 0.82 ADRA2A (0.41) PLK1PLK3CYP2C9ADRA2AADRA2B
SCHEMBL19205668 0.72 MAPT (0.33) JAK2
SCHEMBL19205669 0.72 MAPT (0.33) JAK2
SCHEMBL18448779 0.68 ADRA2A (0.48) FFAR2ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 — — WO disclosed
Send feedback